Abstract. The YF//gene encodes a raslike, GTPbinding protein that is essential for growth of yeast cells. We show here that mutations in the yptl gene
TP-BINmNG proteins play diverse roles in the cell (Bourne, 1986) . Despite this diversity in function, they may share a common mechanism. Many are thought to operate as molecular switches, changing conforrnation depending on the nucleotide bound. In their GTPbound state, they each interact with a specific cellular component to stimulate or inhibit its function. Hydrolysis of bound GTP to GDP (guanosine 5'-diphosphate) I by the binding protein curtails interaction. Exchange of GTP for GDP is often under control of another protein. This common scheme can be used for signal transduction (Neer and Clapham, 1988) , as in the case of Gs, G~ and transducin (Stryer and Bourne, 1986) , or to coordinate the events of a multistage reaction as in the cases of the elongation factors (Kaziro, 1978) . One subset of GTP-binding proteins has been defined as raslike because all of the members share significant sequence identity with the mammalian ms proto-oncogene products. While one of these proteins, the RAS2 protein of yeast, has been clearly implicated in regulating the function of adenylate cyclase in response to nutrient starvation, the functions of the other raslike proteins are less clear.
We have focused on the function of one specific raslike protein of yeast, the product of the YPT/gene. First identiffed as an open reading frame adjacent to the actin gene (Gallwitz et al., 1983) , the YP'H gene has been shown by in vitro mutagenesis and gene replacement to be essential for vegetative growth of yeast (Schmitt et al., 1986; Segev and Botstein, 1987) . Study of conditional lethal mutants has led to two very different hypotheses regarding the function of the YPT/product. Schmitt et al. (1988) have argued that its primary function is the regulation of intracellular calcium levels. This proposal is based on the finding that a yptl mutant strain exhibits increased 45Ca++ uptake and has a growth defect that can be partially suppressed by high extracellular levels of Ca ++. Both Schmitt et al. (1988) and Segev et al. (1988) have noted a block in the secretion of invertase at an early stage of the secretory pathway and an accumulation of membrane bounded organelles at the restrictive temperature. Schmitt et al. (1988) have interpreted this phenotype to be a secondary consequence of the alteration in intracellular Ca ++ concentration, while Segev et al. (1988) argue that the primary role of the Yptl protein is in vesicular transport through the Golgi complex. Their argument is based on the apparent association of the Yptl protein with the Golgi apparatus in yeast. They also note the presence of a cross reacting Yptl homologue in the Golgi complex of a mammalian cell line. By this proposal, the Yptl protein would play a role at an early stage of transport that is analogous to the role shown for the structurally related Sec4 protein at a later stage, vesicular transport from the Golgi complex to the plasma membrane (Salminen and Novick, 1987; Goud et al., 1988) .
In this report, we investigate the role of the YPT/ gene product in the transport of pro-or-factor from the ER to a site of outer chain mannose addition in the Golgi apparatus. We have used a recently developed in vitro transport assay (Ruohola et al., 1988) to probe the site of action of the YPT/gene product and to clarify the ambiguity regarding the primary defect in the yptl mutant. We have also screened for genetic interactions between the YPT/gene and other genes that are required for early stages of transport.
Materials and Methods

Genetic Techniques
Yeast strains used in this study are listed in Table I . Genetic crosses, sporulation of dipioids, and dissection of tetrads were done as described by Sherman et al. (1974) . Transformation of yeast was done by the method of alkali cation treatment (Ito et al., 1983) . Growth properties were assessed by replica stamping strains onto YPD (1% yeast extract, 2% Bactopeptone, and 2% glucose) plates that were then incubated at 250C, 30°C, 340C, and 37°C and scored after 24 h.
GTP Binding
Lysates were prepared by vortexing cells in the presence of glass beads, followed by addition of SDS to 2% and heating to 100*C for 3 min. Proteins were displayed by electrophoresis on 12% polyacrylamide gels and then transferred to nitrocellulose. GTP-binding proteins were revealed by the method of Lapetina and Reep (1987) .
Growth Conditions
Yeast cells used for the preparation of permeabilized yeast cells (PYC); 3,000 g supernatant ($3) fractions; high speed, 100,000 g, supernatant (HSS); and high speed, 100,000 g pellet (HSP) fractions were usually grown in YPD medium (1% yeast extract, 2% bactopeptone, and 2% glucose). Strains containing high copy plasmids were grown in Wickerham's minimal medium under selective conditions; for radiolabeling experiments, sulfate salts were replaced by chloride salts and ammonium sulfate was added to a final concentration of 100 or 25 #M. Cells grown in minimal medium were incubated for approximately one generation at 25°C in YPD medium and then used for the preparation of $3 fractions. The growth medium was changed by harvesting cells at room temperature in a clinical centrifuge. Cell densities were measured in a 1-cm quartz cuvette at 599 nm in a spectrophotometer (4054 UV/Visible Biochrom Ultrospec Plus; LKB Instruments Inc., Bromma, Sweden).
In Vitro Transport Assay
Prepro-c~-factor was transcribed and translated (Ruohola et al., 1988) by a modification of the procedure used by Hansen et al. (1986) . Yeast lysates containing [32S]methionine labeled prepro-c~-factor were used immediately after translation or frozen at -80°C. The transport assay was performed in two stages as described before (Ruohola et al., 1988) . In the first stage of the reaction, prepro-c~-factor translated in a yeast translation lysate was translocated into the ER lumen retained within the PYC. Cells, containing the ER form of oz-factor, were pelleted, washed once with transport buffer, resuspended in the same buffer, and used to perform the second stage of the reaction. At the end of this reaction, the Golgi form of c~-factor resides outside the PYC. To separate the reaction product from the PYC, the cells were pelleted during a 23-s centrifugation in a microfuge (Fisher Scientific Co., Pittsburgh, PA) and the supernatant was treated with trypsin (470 #g/ml) for 20 min at 0°C and then with trypsin inhibitor (940 #g/ml) for 5 rain at 0*C. Samples were heated to 100°C in the presence of 1% SDS and c~-factor was immunoprecipitated with anti-ct-factor antibody as described before (MATt, , ypt l-l) was backcrossed four times to wild type. (Ruohola et al., 1988) or by binding to Con A Sepharose (Sigma Chemical Co., St. Louis, MO) in the presence of high salt wash (500 mM NaCI, 1% Triton X-100, 20 mM Tris, pH 7.5). When Con A Sepharose was used, samples were incubated for 2 h at room temperature in the presence of 90 #1 of a 20% (vol/vol) solution. The beads were washed twice with 1 ml of low salt wash buffer (150 mM NaCI, 1% Triton X-100, 0.1% SDS, 15 mM Tris, pH 7.5), twice with 1 ml of urea wash buffer (2 M urea, 0.2 M NaCI, 1% Triton X-100, 0.1 M "Iris, pH 7.5), once with 1 ml of high salt wash buffer and once with 1 ml of Tris-sait buffer (50 mM NaCl, 10 mM "Iris (pH 7.5). PYC, $3, HSS, and HSP fractions were prepared as described before (Ruohola et al., 1988) , or, were prepared from regenerated spheroplasts that were kept as a packed pellet overnight at 0*C or frozen at -80°C and lysed after thawing. To compare the ypt/and sec4 mutants with wild type cells, $3 fractions and PYC were assayed at the same protein concentration. The protein concentration of each fraction was measured using the Bradford assay (1976) with ovalbumin as a protein standard. Samples were electrophoresed in a 12% SDS polyacrylamide slab gel.
In Vivo Labeling and lmmunoprecipitation
Cultures grown overnight at 25°C in minimal medium were supplemented with 100 #M ammonium sulfate, 2% glucose, histidine, and uracil. Cells (10D599 U) were pelleted, resuspended in 0.5 ml of minimal medium supplemented with 25 t~M ammonium sulfate, histidine, uracil, and 200 #Ci of [35S]sulfate. At the end of a 30-min incubation at 37°C, the cells were washed with 1 ml of cold 10-mM sodium azide, converted to spheroplasts and lysed as described before (Newman and Ferro-Novick, 1987) . The lysate was centrifuged at 100,000 g for 1 h in a rotor (Beckman Instruments Inc., Palo Alto, CA) and carboxypeptidase Y (CPY) was immunoprecipitated from the clarified lysate with anti-CPY antibody as described before (Newman and Ferro-Novick, 1987) .
Results
Isolation of a New Allele of yptl
A new allele of yptl was found during a screen of existing secretory (sec) mutants for defects in GTP-binding proteins.
Lysates were prepared from mutants that were grown at 25°C in YPD medium, and shifted to 37°C for 1 h. Cellular proteins were separated by electrophoresis on SDS polyacrylamide gels. After transfer to nitrocellulose, GTP-binding proteins were revealed by incubation of the filter with [o~32P]GTP and autoradiography. Typically 5 bands are seen by this procedure (Goud et al., 1988) . One strain, NY45, failed to show binding at the position corresponding to the Yptl protein (23 kD). Since NY45 carries the sec3-2 mutation, it was backcrossed to a wild-type strain, and tetrads were analyzed for linkage of the sec3-2 growth defect and the loss of the Yptl, GTP-binding band. The two phenotypes were found to be unlinked. Temperature-resistant spores that exhibited a defect in the Yptl band were found, as were temperature-sensitive strains that showed normal binding by the Yptl band. The new mutation was tentatively defined as yptl-2 and was backcrossed two additional times to a wildtype strain. The yptl-2 mutation, by itself, confers only a slight growth defect, which is most apparent in single colony growth at 37°C on YPD plates. Therefore, this defect is much more subtle than the previously isolated yptl-1 mutation (Segev and Botstein, 1987 ) that causes very slow growth at intermediate temperatures, 25-30°C (grows at approximately half the rate of wild type at 25°C), and lethality at both higher (37°C) and lower temperatures (14°C).
The identity of the new allele was verified by complemenration analysis. The mutant was transformed with plasmids carrying the wild-type allele of YPT/. The transformants and the parental strain were evaluated on a GTP-binding blot (Fig. 1) . The parental yptl-2 strain, NY703, showed no bind- 
The yptl Mutant Blocks Transport to the Vacuole In Vivo
Conditional lethal mutations in the yptl gene disrupt the transit of invertase (Segev et al., 1988; Schmitt et al., 1988) . This block in export leads to the accumulation of a network of ER and an aberrant form of the Golgi apparatus at the restrictive temperature (Schmitt et al., 1988; Segev et al., 1988) . It was previously shown that the bet and sec ERaccumulating secretory mutants block the transport of the vacuolar protease CPY (Stevens et al., 1982; Newman and Ferro-Novick, 1987) . CPY follows the early portion of the secretory pathway. In the ER, it is glycosylated at four sites, yielding the 67-kD, pl form (Haslik and Tanner, 1978) . Subsequent transport to the Golgi apparatus leads to extension of the carbohydrate chains resulting in the 69-kD, p2 form. Just before or upon arrival at the vacuole, an 8-kD NH2 terminal propeptide is removed, producing the mature form. Early blocked secretory mutants arrest transit from the ER to the Golgi complex at 37°C, accumulating the pl form of CPY (67 kD).
CPY transport was examined in the conditionally lethal yptl-1 allele. Mutant cells were grown at 25°C and then immediately labeled with [3sS]sulfate upon a 30-min shift to the restrictive temperature (37°C). Cells were converted to spheroplasts by enzymatic removal of the yeast cell wall, lysed with detergent, and CPY was immunoprecipitated with anti-CPY antibody. As shown in Fig. 2 , lane 1, wild-type cells synthesized the glycosylated, processed, mature form of CPY (61 kD); trace amounts ofpl and p2 CPY were also detected. In contrast, the yptl-I mutant synthesized a form of CPY similar in mobility to the pl form (lane 2). This form of CPY was also synthesized in seclS-1 (lane 3), a previously identified ER-accumulating mutant (Novick et al., 1980) .
In some experiments the form of CPY in yptl-1 lysates was slightly higher in apparent molecular mass than was the pl form in seclS-1 lysates. The significance of this slight shift is addressed in the Discussion. Although the yptl-2 strain (NY703) is not a conditional lethal mutant, pulse chase experiments revealed that transit of CPY to the vacuole, as measured by the rate of appearance of the mature form, was slower than in wild-type cells (not shown).
A Defect in the Yptl Protein Disrupts Transport In Vitro
Mutations in the yptl gene disrupt transit through the early stage of the secretory pathway in vivo (Segev et al., 1988; Schmitt et al., 1988) . To determine whether this defect could be reproduced in vitro, we isolated fractions from NY703 and examined their ability to support transport. Transport from the ER to the Golgi complex in vitro can be monitored using a gel assay (Ruohola et al., 1988) . The marker protein used in this assay is a precursor to the secreted pheromone or-factor (prepro-ot-factor). In vivo prepro-a-factor is synthesized as a 19-kD proprotein that is converted to a 26-kD polypeptide by the addition of three NH2-linked core oligosaccharide units in the lumen of the ER. Outer chain carbohydrate, a highly branched structure consisting of 50-150 mannose residues (Ballou, 1982) , is added to pro-a-factor in the Golgi complex (Julius et al., 1984) . This modification results in a protein that migrates as a higher molecular mass heterogeneous smear on SDS polyacrylamide gels. In the assay we developed, transport is monitored by following the processing of pro-or-factor. In the first stage of this two stage assay, in vitro translated prepro-otfactor enters PYC and is translocated across the lumen of the ER where it is glycosylated (26-kD polypeptide). In the second stage, the ER form of or-factor is converted to the high molecular mass Golgi form. Conversion to the Golgi form is dependent upon the presence of ATP and the supernatant of a yeast lysate spun at 3,000 g ($3 fraction). An advantage of our transport assay (Ruohola et al., 1988) is the resolution of the membrane components: the ER, or donor compartment, resides in the permeabilized cells while the acceptor Golgi compartment is added exogenously to the cells. At the end of the reaction, the high molecular mass Golgi form is found outside the PYC with the exogenously added acceptor. Fig. 3 A illustrates that an $3 fraction, obtained from the yptl-2 mutant, failed to support transport to a site of extensive outer chain addition in vitro when assayed with wild-type PYC (Fig. 3 , compare lanes 1 and 2 with 3). Although the high molecular mass Golgi species was not formed, u-factor however, mutant HSP failed to support transport when assayed with a wild-type HSS and wild-type PYC (Fig. 4 , compare lanes 1 and 5). The yptl-1 allele was also examined in the in vitro assay. Fractions from the ypt/-1 mutant were prepared from cells grown at 25°C and then assayed at 20°C. As was the case with ypt/-2, the HSP was the only fraction that was found to be defective in the yptl-I lysate (not shown).
Thus, mutations in the Yptl protein specifically affect the Golgi compartment but not the permeabilized cells or the soluble factors required for transport.
In an earlier report (Ruohola et al., 1988) , we demonstrated that, a portion of the 26-kD species and all of the high molecular mass Golgi form of a-factor, reside outside the PYC at the end of the assay. The released 26-kD species is contained within a vesicular reaction intermediate. Release of this intermediate from the permeabilized cells is dependent upon the presence of ATP (our unpublished results). Fig. 3 shows that when transport is blocked in the yptl-2 mutant, a 28-kD species accumulates. To determine whether this form of t~-factor remains within the cells or is released during the reaction, wild-type cells were incubated with a mutant yptl-2 $3 fraction for 90 min at 20°C. Following this reaction, the permeabilized cells were pelleted in a microfuge, and the forms of pro-o~-factor residing in the supernamigrating just above the 26-kD species at an approximate apparent molecular mass of 28 kD was observed. This band is not always well resolved from the 26 kD form. If the $3 fraction was obtained from a yptl-2 mutant strain that harbored a low copy number, centromere-based plasmid carrying a wild-type copy of the YPT/gene (pNB166), no defect was observed (Fig. 3, lane 4) . This indicated that pNB166 complemented both the transport defect observed in vitro and the GTP-binding defect (Fig. 1) , providing additional evidence that NY703 harbored a mutation in the ypt/gene and established that the ypt/mutation is responsible for the transport defect. The ypt/-2 mutation did not affect the ability of the permeabilized cells to support transport, since mutant cells were fully functional when assayed in the presence of a wildtype $3 fraction (Fig. 3 B, compare lanes 1 and 2) . Thus, a defect in the Yptl protein disrupts transit to the site of extensive glycosylation in the Golgi complex in vitro and this defect is associated with the $3 fraction and not with the PYC.
The Golgi Complex Is Defective in the yptl Mutant
The $3 fraction can be further subfractionated at 100,000 g for 1 h to generate HSS and HSP fractions. The soluble factors are provided by the HSS, while the HSP contains the functional Golgi apparatus (Ruohola et al., 1988) . Since the function of each compartment can be assayed independently, this has enabled us to test the ability ofyptl mutant fractions to support transport in vitro.
The HSS obtained from the yptl-2 mutant was found to support transport when assayed in the presence of wild-type HSP and wild-type PYC (Fig. 4, compare lanes 1 and 4) ; lanes I and 4) ; however, the yptl-2 HSP failed to support transport when assayed in the presence of a wild type HSS (lane 5). Mutant HSS failed to transport the ER form of or-factor to the Golgi complex in the absence of a wild-type HSP and wild-type HSS failed to support transport in the absence of a wild-type HSP (not shown). The two major bands appearing below the 26-kD species represents partially core glycosylated pro-a-factor. 2) or with wild-type (SFNY26-6A) cytosol in the presence of a mutant HSP fraction (lane 3). At the end of the assay, the samples were centrifuged for 23 s at room temperature in a microfuge (Fisher Scientific Co.) and processed as described in Materials and Methods. The forms of a-factor residing in the cell pellet and released into the cell supernatant were examined by SDS-PAGE. Most of the 26-kD species and all of the 28-kD form of,-factor was released into the supernatant during the reaction (compare lanes I and 2). The appearance of the 28-kD species was dependent upon addition of a HSP fraction that contained the mutant Golgi complex (lane 3). The 28-kD species was not observed when the PYC were incubated with mutant HSS and ATP (not shown).
tant and remaining in the cell pellet were examined. We observed that most of the 26-kD species and all of the 28-kD form of a-factor were found in the supernatant (Fig. 5 , compare lanes I and 2). The formation of the 28-kD species was dependent upon addition of a mutant HSP fraction that contains the yptl Golgi complex (Fig. 5, lane 3) . This form of a-factor was not seen when the PYC were incubated with mutant cytosol (not shown). This finding suggests that the 28-kD species is associated with the yptl mutant Golgi fraction that was added exogenously to the permeabilized cells during the assay.
Fractionation studies have revealed the existence of a soluble pool of Yptl protein in wild-type cells (Molenaar et al., 1988) . Potentially, the wild-type soluble pool could attach to the yptl mutant Golgi apparatus upon preincubation in vitro. 
YPT1 and Ca++Regulation
One proposal regarding the role of the Yptl protein is that it functions to regulate intracellular calcium levels. By this proposal, the effects of yptl mutations on protein transport are a secondary consequence of altered intracellular levels of calcium. The in vitro transport assay offers a critical test of this hypothesis. Because the cytoplasmic space is readily accessible during the assay, we can determine whether the yptl transport defect can be overcome by the direct addition of calcium to the reaction mixture. The assay was performed using wild-type permeabilized cells and either a wild-type, yptl-1, or yptl-2 mutant $3 fraction. As was previously shown, (Fig. 3 A, lane 3 and Fig. 4, lane 2) , the mutant $3 fractions are defective. The addition of CaCI2, to a final added concentration of 10/zM, did not restore function to the defective fractions, nor did it lower the efficiency of the wild-type reaction (Fig. 7, lanes 1, 2, 4 , and 5). To verify that this level of Ca ++ did not interfere with the assay, the reaction was performed in the presence of apyrase, an enzyme that hydrolyses ATE Since the addition of Ca ++ did not bypass the requirement for ATP (Fig. 7, lanes 3 and 6) , the reaction seen in the presence of increased Ca ++ is authentic.
The use of calcium/EGTA buffers allows a more accurate definition of the free calcium concentration. Unfortunately EGTA causes an inhibition of the assay that cannot be overcome by the addition of calcium (not shown). This may reflect the chelation of a trace divalent cation required for the assay. A likely candidate is manganese, since this ion is required for the activity of the mannosyl transferases that add outer chain carbohydrate (Nakajima and BaUou, 1975) . The ER and mitochondria can take up Ca++, and thus, when Ca ++ is added to the transport assay, they can act as Ca ++ sinks. To try to assess the free Ca ++ concentration during the reaction, a mock assay was performed with the addition of several concentrations of 4sCa++. Following the reaction, the mix was centrifuged at 100,000 g for 1 h and the supernatant was counted. Based on this data we can estimate that the addition of 50/zM Ca ++ to the reaction mixture containing an $3 fraction from the yptl-2 mutant, results in a free Ca ++ concentration of at least 6/~M, and the addition of 10 t,M Ca ++ results in a free concentration of at least 0.9 #M. The true level of free Ca ++ may be somewhat higher as a result Figure 6 . The defect in the yptl mutant can be complemented in vitro. Transport was observed when a wild-type (SFNY26-tA) $3 fraction was incubated with wild-type PYC (lane 1). This $3 fraction was subfractionated into HSS and HSP fractions that were active (lane 2). No activity was seen (lane 3) when the wild-type HSS was incubated with the yptl HSP (NY703). However, transport was restored if the wild-type HSS was preincubated with the ypt/HSP for 35 min at 20°C in the presence of 1 mM DIT 0ane 4). of Ca ++ present in the S3 fraction as well as Ca ++ contaminating the added water. Despite this level of free Ca ++, the mutant reaction mixture remains inactive.
Genetic Interactions between yptl and Early-blocked Secretory Mutants
Previous studies have shown a strong genetic interaction between the SEC4 gene and a number of the other SEC genes required at a late stage of the secretory pathway (Salminen and Novick, 1987) . Interaction with SEC4 has been detected in two ways. It was first observed that introducing a second wild-type copy of SEC4 into a subset of vesicle accumulating sec mutants partially suppressed their growth defect. It was subsequently shown that double mutants carrying both the sec4-8 mutation as well as a temperature-sensitive mutation in one of the interacting genes were inviable at all temperatures, although the single mutants grew well at 250C. The same set of mutants that were partially suppressed by transformation with a plasmid carrying the SEC4 gene, were lethal when combined with sec4-8. This set of mutants was restricted to vesicle accumulators, mutants blocked at other stages of the secretory pathway showed no interaction.
The similarity in structure between the Sec4 and Yptl proteins suggests that they may function by a similar mechanism, but at two distinct stages of the secretory pathway. For this reason, one might expect to see interaction of YPT/with a subset of the mutants blocked in transport to or through the Golgi complex. We have screened for suppression of the growth defect of mutants blocked at or before the Golgi apparatus by overexpression of YPT/. Representative alleles of sec and bet mutants were transformed with pNB167, a multicopy plasmid carrying Y/U1. Only a very slight improvement in the growth of the sec21-1 strain was seen upon transformation. No change in the growth properties of the other mutants was detected.
We next looked for lethality of double mutants. A yptl-I strain was crossed to representatives of each of the complementation groups of sec13, sec16, sec17, sec18, sec20, sec21, sec22, sec23, bet1, and bet2) and Golgi-blocked (sec7and sec14) mutants (Novick et al., 1980; Newman and Ferro-Novick, 1987) . Analysis of the tetrads revealed that in crosses to seven mutants (secT-l, sec12-4, sec21-1, sec22-3, sec23-1, bet1-1, and bet2-1) , a large number of spores failed to give rise to viable colonies. The pattern of inviability suggested that in these cases it was the double mutants that were inviable (see Table II ). The significance of this result was somewhat diminished by the fact that the ypt/-1 single mutant grew quite slowly at 25°C. In other words, lethality may be caused by the additive effects of two unrelated partial growth defects rather than by a specific, functional interaction of two gene products. We therefore repeated this series of crosses using the yptl-2 allele. This allele shows no detectable growth defect at 25°C, and is only slightly impaired at 37°C. Lethality of double mutants was not observed in crosses with yptl-2, yet in several cases 
growth of the double mutants failed at temperatures significantly reduced from the threshold temperature of the parental strain. Particularly dramatic was the result of the cross between yptl-2 and bet2-1. Both of these mutations confer little if any growth defect at 25°C, and yet the double mutants were nearly inviable at this temperature. Weaker effects were seen in the crosses of yptl-2 to sec7-1, secI4-3, sec2I-1, and betI-1. In the crosses with sec7-1 and secl4-3, the growth of the double mutants failed at 33.5°C, while the sec7-1 and secl4-3 single mutants failed to grow at 37°C. In the crosses with sec21-1 and betl-1, the growth of the double mutants failed at 30°C, while the sec21-1 and beth single mutants were able to grow at 30°C, though not at 36°C.
Discussion
We have used an in vitro assay (Ruohola et al., 1988) to characterize the role of the YF//gene product in intracellular protein transport in yeast. For our analysis, we have employed two different mutant alleles, yptl-1 (Segev and Botstein, 1987) and yptl-2. The yptl-1 allele is a conditional lethal allele that grows poorly at all temperatures (Segev et al., 1988) . A phenotype observed in vitro with this allele could conceivably be an indirect consequence of its slow growth.
In contrast, the yptl-2 allele grows well at all temperatures;
however, a small but perceptible reduction in growth is observed on YPD plates at 37°C. The growth defects ofyptl-1 and yptl-2 correlate well with the defects seen in the transport of CPY to the vacuole in vivo: yptl-1 exhibits a complete block, while yptl-2 exhibits only a slowing of transport. The yptl-2 allele is useful for in vitro studies since this mutant displays a dramatic block in transport in vitro (Fig. 3 A) , and yet is not conditional lethal for growth. The finding that a particular mutation affects protein transport to a greater degree in vitro than in vivo suggests that the reaction catalyzed by the gene product is relatively more rate limiting in vitro. Several lines of evidence suggest that Yptl is required for transport between an early stage and a later stage of the Golgi apparatus. The form of pro-a-factor that accumulates in a yptl mutant in vitro is intermediate in molecular mass between the 26-kD core glycosylated form and the high molecular weight form that accumulates in the Golgi apparatus. Formation of this 28-kD species is dependent upon addition of the mutant HSP fraction to the permeabilized cells. This finding suggests that the 26-kD form of a-factor may be transported to another membrane compartment for conversion to the 28-103 form. Since it is known that the HSP fraction contains the functional Golgi apparatus in this reaction (Ruohola et al., 1988) , a likely candidate is the cis compartment of the Golgi apparatus. The 28-kD species is found outside the permeabilized cells after the reaction, consistent with the hypothesis that pro-a-factor is transported to a compartment that is added exogenously to the cells. The 28-kD form of pro-a-factor may represent an intermediate in the normal transport reaction since we have observed this species in wild type at early times of transport. It is depleted as the reaction continues on to yield the high molecular mass form (Bacon and Ferro-Novick, unpublished results). Our studies do not exclude the possibility that Yptl is also required for transport from the ER to the Golgi apparatus. Significantly less of the 26-kD form of pro-a-factor is convetted to the 28-kD form in the presence of a yptl-2 $3 fraction than is converted to the high molecular mass form in the presence of a wild-type $3 fraction. Therefore, the yptl-2 defect may lead to a partial block in transport from the ER to the Golgi apparatus in addition to a block in transport through the Golgi apparatus.
Although the nature of the modification leading to formation of the 28-kD form is not known, the addition of several mannose residues to each of the three cores of the 26-kD form of pro-a-factor could explain the shift in molecular mass. The same modification could explain the slight shift in molecular mass seen in CPY relative to the ER form; however, the larger size of the polypeptide would make the increase in molecular mass more difficult to detect. A more apparent shift from the core glycosylated form is seen in the case ofinvertase (Segev et al., 1988) . Invertase contains 9-10 core oligosaccharide units; the addition of several mannose residues to each core should be readily observed for this protein.
Immunofluorescence studies with anti-Yptl antibody in both yeast and mammalian cells suggest that the Yptl protein and its mammalian homologue are primarily associated with the Golgi apparatus (Segev et al., 1988) , although fractionation studies indicate that a soluble pool may exist as well (Molenaar et al., 1988) . Our in vitro findings (Fig. 4) establish that a defect in the Yptl protein leads to a loss of Golgi function without affecting the permeabilized cells or the soluble factors required for transport. This defect is observed with either the yptl-1 or yptl-2 allele. Our findings are therefore consistent with the immunofluorescence localization studies.
Strong genetic interactions have been demonstrated between the SEC4 gene and a number of the other genes required for vesicular transport from the Golgi complex to the cell surface (Salminen and Novick, 1987) . Because of the close structural similarity of the Sec4 protein with the Yptl protein, we have screened for analogous genetic interactions between YPT/and genes required for early stages of transport. In general, YP/7 does not display as strong a pattern of genetic interaction as does SEC4. Overexpression of YPT/ does not lead to strong suppression of the growth defects resulting from mutations in early stages of the secretory pathway, and lethality of double mutants is only seen with the yptl-1 allele and not the yptl-2 allele. Nonetheless, the genetic interactions observed may signify a functional interaction of the gene products. The strongest effect is seen with bet2-1, a mutant blocked in transport from the ER to the Golgi apparatus. Since Yptl is required for transport through the Golgi apparatus, the interactions seen may reflect the involvement of the BET2 gene product at this stage of the pathway in addition to its demonstrated role in transport from the ER to the Golgi apparatus. Alternatively, the genetic interaction may reflect the involvement of the YPT/gene product in transport from the ER in addition to its role in transport through the Golgi apparatus.
Our data suggests that the transport defect in the yptl mutants is probably not a consequence of a failure to correctly regulate intracellular calcium levels. Addition of calcium to the in vitro assay reaction does not bypass the yptl-2 defect.
In total, our results are consistent with, though do not definitively establish, the possibility that the Yptl protein plays a direct role in the control of vesicular traffic in the Golgi apparatus.
Earlier studies have shown that the nonhydrolyzable analogue, GTPTS, is a potent inhibitor of vesicular transport through the Golgi apparatus (Melanfon et al., 1987) . The mammalian homologue of Yptl is a possible target of GTP3,S action. Like other GTP-binding proteins, Yptl must undergo a cycle of binding and hydrolyzing GTP to fufill its function (Bourne, 1988) . GTPTS would prevent Yptl from returning to its GDP-bound conformation, and therefore block the cycle. Further work will be required to understand the mechanism by which Yptl functions to mediate transport and the role that GTP binding and hydrolysis play in this mechanism.
